Toward Building Better Biomarkers Statistical Methodology
Clinical Considerations There is concern regarding the clinical utility of biomarkers in kidney disease (Acute Kidney Injury [AKI], Chronic Kidney Disease [CKD], various forms of glomerulonephritis [GN], and polycystic kidney disease [PKD]) for prediction of diverse clinical outcomes (such as loss of renal function, development of cardiovascular disease, diminution of quality of life, death), as well as in drug development (for refinement of risk stratification or drug response). There is dissatisfaction with the results of published biomarker studies and the lack of uptake of biomarkers in clinical practice in patients ...
Source: Videocast - All Events - December 1, 2014 Category: Journals (General) Tags: Upcoming Events Source Type: video
Lawrence Tim Goodnough, MD - Anemia in Chronic Kidney Disease: Practical Strategies to Optimize the Use of Iron Therapy
Anemia in Chronic Kidney Disease: Practical Strategies to Optimize the Use of Iron Therapy (Source: PeerView CME/CE Video Podcast - Hematology)
Source: PeerView CME/CE Video Podcast - Hematology - August 11, 2014 Category: Hematology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video